Antilipolytic effect of N6,2'-O-dibutyryl-3' ,5'-adenosine monophosphate in vivo.
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000273:Adipose Tissue / Q000187:drug effects; D000818:Animals; D000242:Cyclic AMP / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats
D000227:Adenine Nucleotides; D005230:Fatty Acids, Nonesterified; D000242:Cyclic AMP; D005990:Glycerol; D009638:Norepinephrine